Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
137.03
+1.44 (1.06%)
At close: Sep 26, 2025, 4:00 PM EDT
135.00
-2.03 (-1.48%)
After-hours: Sep 26, 2025, 7:28 PM EDT
Insmed Employees
Insmed had 1,271 employees as of December 31, 2024. The number of employees increased by 359 or 39.36% compared to the previous year.
Employees
1,271
Change (1Y)
359
Growth (1Y)
39.36%
Revenue / Employee
$313,222
Profits / Employee
-$813,801
Market Cap
28.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,271 | 359 | 39.36% |
Dec 31, 2023 | 912 | 176 | 23.91% |
Dec 31, 2022 | 736 | 123 | 20.07% |
Dec 31, 2021 | 613 | 92 | 17.66% |
Dec 31, 2020 | 521 | 86 | 19.77% |
Dec 31, 2019 | 435 | 62 | 16.62% |
Dec 31, 2018 | 373 | 159 | 74.30% |
Dec 31, 2017 | 214 | 53 | 32.92% |
Dec 31, 2016 | 161 | 36 | 28.80% |
Dec 31, 2015 | 125 | 36 | 40.45% |
Dec 31, 2014 | 89 | 28 | 45.90% |
Dec 31, 2013 | 61 | 20 | 48.78% |
Dec 31, 2012 | 41 | -1 | -2.38% |
Dec 31, 2011 | 42 | 2 | 5.00% |
Dec 31, 2010 | 40 | 25 | 166.67% |
Dec 31, 2009 | 15 | -82 | -84.54% |
Dec 31, 2008 | 97 | 3 | 3.19% |
Dec 31, 2007 | 94 | -63 | -40.13% |
Dec 31, 2006 | 157 | 72 | 84.71% |
Dec 31, 2005 | 85 | 30 | 54.55% |
Dec 31, 2004 | 55 | 35 | 175.00% |
Dec 31, 2003 | 20 | -3 | -13.04% |
Dec 31, 2002 | 23 | -37 | -61.67% |
Dec 31, 2001 | 60 | 20 | 50.00% |
Dec 31, 2000 | 40 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INSM News
- 5 days ago - Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 - PRNewsWire
- 17 days ago - Insmed Incorporated (INSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 22 days ago - Insmed Incorporated (INSM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - Insmed To Present at September Investor Conferences - PRNewsWire
- 5 weeks ago - Lung Disease-Focused Insmed 'Must-Own' Name For Investors - Benzinga
- 6 weeks ago - FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease - Benzinga
- 6 weeks ago - US FDA approves Insmed's lung disease drug - Reuters